Molecular and clinical aspects of embryotoxicity induced by acetylcholinesterase inhibitors

Autor: Tsiaoussis, J., Hatzidaki, E., Docea, A.O., Nikolouzakis, T.K., Petrakis, D., Burykina, T., Mamoulakis, C., Makrigiannakis, A., Tsatsakis, A.

Publikováno v: In Toxicology 1 November 2018 409:137-143

Central data monitoring in the multicentre randomised SafeBoosC-III trial:a pragmatic approach

Autor: Olsen, M. H., Hansen, M. L., Safi, S., Jakobsen, J. C., Greisen, G., Gluud, C., Pellicer, A., Bargiel, A., Hopper, A., Truttmann, A., Klamer, A., Heuchan, A. M., Memisoglu, A., Krolak-Olejnik, B., Rzepecka, B., Loureiro, B., Lecart, C., Hagmann, C., Ergenekon, E., Hatzidaki, E., Mastretta, E., Dempsey, E., Papathoma, E., Lou, F., Dimitriou, G., Pichler, G., Vento, G., Hahn, G. H., Naulaers, G., Cheng, G., Fuchs, H., Ozkan, H., De Las Cuevas, I., Sadowska-Krawczenko, I., Tkaczyk, J., Sirc, J., Zhang, J., Mintzer, J., De Buyst, J., Mccall, K., Bober, K., Sarafidis, K., Bender, L., Lopez, L. S., Chalak, L., Yang, L., Cornette, L., Arruza, L., Baserga, M., Stocker, M., Agosti, M., Cetinkaya, M., Alsina, M., Fumagalli, M., Suarez, O. L., Otero, O., Baud, O., Zafra, P., Agergaard, P., Maton, P., Viellevoye, R., del Rio Florentino, R., Lauterbach, R., Borregas, S. P., Nesargi, S., Rite, S., Rao, S., Zeng, S., Pisoni, S., Hyttel-Sorensen, S., Fredly, S., Oguz, S., Karen, T., Szczapa, T., Gao, X., Xu, X., Yin, Z.

Publikováno v: Olsen, M H, Hansen, M L, Safi, S, Jakobsen, J C, Greisen, G, Gluud, C, Pellicer, A, Bargiel, A, Hopper, A, Truttmann, A, Klamer, A, Heuchan, A M, Memisoglu, A, Krolak-Olejnik, B, Rzepecka, B, Loureiro, B, Lecart, C, Hagmann, C, Ergenekon, E, Hatzidaki, E, Mastretta, E, Dempsey, E, Papathoma, E, Lou, F, Dimitriou, G, Pichler, G, Vento, G, Hahn, G H, Naulaers, G, Cheng, G, Fuchs, H, Ozkan, H, De Las Cuevas, I, Sadowska-Krawczenko, I, Tkaczyk, J, Sirc, J, Zhang, J, Mintzer, J, De Buyst, J, McCall, K, Bober, K, Sarafidis, K, Bender, L, Lopez, L S, Chalak, L, Yang, L, Cornette, L, Arruza, L, Baserga, M, Stocker, M & The SafeBoosC-III Trial Group 2021, ' Central data monitoring in the multicentre randomised SafeBoosC-III trial : a pragmatic approach ', BMC Medical Research Methodology, vol. 21, 160 . https://doi.org/10.1186/s12874-021-01344-4
Olsen, M H, Hansen, M L, Safi, S, Jakobsen, J C, Greisen, G, Gluud, C & The SafeBoosC-III Trial Group 2021, ' Central data monitoring in the multicentre randomised SafeBoosC-III trial – a pragmatic approach ', BMC Medical Research Methodology, vol. 21, no. 1, 160 . https://doi.org/10.1186/s12874-021-01344-4
Olsen, M H, Hansen, M L, Safi, S, Jakobsen, J C, Greisen, G, Gluud, C, The SafeBoosC-III Trial Group & Bender, L 2021, ' Central data monitoring in the multicentre randomised SafeBoosC-III trial – a pragmatic approach ', BMC Medical Research Methodology, vol. 21, no. 1, 160 . https://doi.org/10.1186/s12874-021-01344-4
BMC Medical Research Methodology
BMC Medical Research Methodology, Vol 21, Iss 1, Pp 1-10 (2021)

Background Data monitoring of clinical trials is a tool aimed at reducing the risks of random errors (e.g. clerical errors) and systematic errors, which include misinterpretation, misunderstandings, and fabrication. Traditional ‘good clinical pract

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67f501ff427e360f947365182c541365
https://findresearcher.sdu.dk:8443/ws/files/190564776/Open_Access_Version.pdf

16P Development of a 3D lung cancer model and evaluation of the efficiency of a human antibody directed against a novel target

Autor: Hatzidaki, E., Apostolou, P., Papasotiriou, I.

Publikováno v: In Annals of Oncology September 2022 33 Supplement 7:S551-S551

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.